BIOSYNTIA ApS: Financial statements 2020
CVR: 34892970
BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 818,132 and a net result of DKK -9,352,159 compared with DKK -8,227,909 the year before. That is an increase of 86.2% compared with the year before. Equity amounted to DKK 26,212,708. The solvency ratio was 83.8%. The company had 21 employees in the financial year.
- Gross Profit
- 818,132 kr.
- Profit/Loss
- -9,352,159 kr.
- Equity
- 26,212,708 kr.
- Total Assets
- 31,291,734 kr.
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 818 t. | -9.4 mio. | 26.2 mio. | 21 |
| 2019 | - | 439 t. | -8.2 mio. | 16.9 mio. | 20 |
| 2018 | - | -2.7 mio. | -9.4 mio. | 25.2 mio. | 18 |
| 2017 | - | 2.2 mio. | -3.2 mio. | 4.8 mio. | 14 |
| 2016 | - | 619 t. | -2.8 mio. | 8 mio. | 8 |
How creditworthy is BIOSYNTIA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
BIOSYNTIA ApS has published its annual report for 2019. Gross profit came to DKK 439,331, and the net result was DKK -8,227,909.
About BIOSYNTIA ApS
BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees. In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity amounted to DKK 32,860,576.
